Table 2.

Cardiovascular clinical studies using ferumoxytol as an MRI contrast agent

Author	Year	N	Age range	Clinical indications
Hope MD et al (63)	2015	102	70.7 ± 10.5 years	AAA, TAA, PE, aortic dissections, aneurysms, AVF, coronaries, carotids, LE vasculature
Cheng JY et al (60)	2015	23	6.3 (0 to 22.1) years	Congenital heart disease
Corwin MT et al (64)	2015	15	Mean 56.9 years	Renal transplant vascular patency
Walker JP et al (32)	2015	10	68 ± 4 years	Peripheral arterial disease
Ruangwattanapaisarn N et al (30)	2014	23	3 days – 18 years	Congenital heart disease
Han F et al (29)	2014	8	3 days – 5 years	Congenital heart disease
Nayak AB et al (28)	2014	10	4–18 years	CKD on hemodialysis – kidney transplant, biliary/liver dysfunction, vascular access
Florian A et al (65)	2014	17	56 ± 9 years	Myocardial infarct imaging (STEMI)
Bashir MR et al (43)	2014	17	62.8 ± 14.9 years	Abdominal pelvic and LE venography
Bashir MR et al (27)	2013	16	54 (36–73) years	Renal transplant vascular patency
Yilmaz A et al (66)	2012	14	51 (45–54) years	Myocardial infarct characterization (STEMI)
Alam SR et al (44)	2012	16	55 (48–65) years	Myocardial inflammation (STEMI)
Sigovan M et al (26)	2012	10	64 (59–82) years	Hemodialysis fistulas
Li W et al (25)	2005	11	64 (19–86) years	Vascular – carotids, thoracic and abdominal aorta, peripheral arteries

AAA abdominal aortic aneurysms, AVF arteriovenous fistulas, CKD chronic kidney disease, LE lower extremity, STEMI ST-elevation myocardial infarction, TAA thoraco-abdominal aneurysms,